Dual, HLA-B27 Subtype-dependent Conformation of a Self-peptide

The products of the human leukocyte antigen subtypes HLA-B*2705 and HLA-B*2709 differ only in residue 116 (Asp vs. His) within the peptide binding groove but are differentially associated with the autoimmune disease ankylosing spondylitis (AS); HLA-B*2705 occurs in AS-patients, whereas HLA-B*2709 does not. The subtypes also generate differential T cell repertoires as exemplified by distinct T cell responses against the self-peptide pVIPR (RRKWRRWHL). The crystal structures described here show that pVIPR binds in an unprecedented dual conformation only to HLA-B*2705 molecules. In one binding mode, peptide pArg5 forms a salt bridge to Asp116, connected with drastically different interactions between peptide and heavy chain, contrasting with the second, conventional conformation, which is exclusively found in the case of B*2709. These subtype-dependent differences in pVIPR binding link the emergence of dissimilar T cell repertoires in individuals with HLA-B*2705 or HLA-B*2709 to the buried Asp116/His116 polymorphism and provide novel insights into peptide presentation by major histocompatibility antigens.

[1]  P. Kraulis A program to produce both detailed and schematic plots of protein structures , 1991 .

[2]  C. Sander,et al.  Errors in protein structures , 1996, Nature.

[3]  F. Granucci,et al.  Analysis of the relationship between viral infection and autoimmune disease. , 2001, Immunity.

[4]  C. Carcassi,et al.  Relevance of residue 116 of HLA‐B27 in determining susceptibility to ankylosing spondylitis , 1995, European journal of immunology.

[5]  David M. Kranz,et al.  TCRs with high affinity for foreign pMHC show self-reactivity , 2003, Nature Immunology.

[6]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[7]  M. Sanner,et al.  Reduced surface: an efficient way to compute molecular surfaces. , 1996, Biopolymers.

[8]  S. Jonjić,et al.  Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.

[9]  J. Russell,et al.  Quantitation of the cell surface level of Ld resulting in positive versus negative selection of the 2C transgenic T cell receptor in vivo. , 1997, Immunity.

[10]  K. Wilson,et al.  Efficient anisotropic refinement of macromolecular structures using FFT. , 1999, Acta crystallographica. Section D, Biological crystallography.

[11]  W. Saenger,et al.  Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus. , 1998, Journal of molecular biology.

[12]  A. Ziegler,et al.  Ankylosing spondylitis: a beta2m-deposition disease? , 2003, Trends in immunology.

[13]  J J Goedert,et al.  Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.

[14]  P. A. Peterson,et al.  Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.

[15]  E A Merritt,et al.  Expanding the model: anisotropic displacement parameters in protein structure refinement. , 1999, Acta crystallographica. Section D, Biological crystallography.

[16]  D. Wiley,et al.  Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.

[17]  G N Murshudov,et al.  Use of TLS parameters to model anisotropic displacements in macromolecular refinement. , 2001, Acta crystallographica. Section D, Biological crystallography.

[18]  Muhammad Asim Khan,et al.  Update on Spondyloarthropathies , 2002, Annals of Internal Medicine.

[19]  M. Harding,et al.  Geometry of metal-ligand interactions in proteins. , 2001, Acta crystallographica. Section D, Biological crystallography.

[20]  J. McCluskey,et al.  Changes at peptide residues buried in the major histocompatibility complex (MHC) class I binding cleft influence T cell recognition: a possible role for indirect conformational alterations in the MHC class I or bound peptide in determining T cell recognition , 1993, The Journal of experimental medicine.

[21]  E Lanino,et al.  Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. , 2001, Blood.

[22]  P I Terasaki,et al.  High association of an HL-A antigen, W27, with ankylosing spondylitis. , 1973, The New England journal of medicine.

[23]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[24]  A. Marina,et al.  Differential Association of HLA-B*2705 and B*2709 to Ankylosing Spondylitis Correlates with Limited Peptide Subsets but Not with Altered Cell Surface Stability* , 2002, The Journal of Biological Chemistry.

[25]  M. Fiorillo,et al.  CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. , 2000, The Journal of clinical investigation.

[26]  P. Gregersen,et al.  RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response , 2002, Genes and Immunity.

[27]  J. Shabanowitz,et al.  Susceptibility to ankylosing spondylitis correlates with the C‐terminal residue of peptides presented by various HLA‐B27 subtypes , 1997, European journal of immunology.

[28]  G W Butcher,et al.  Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa. , 2001, Immunity.

[29]  R D Sturrock,et al.  Ankylosing spondylitis and HL-A 27. , 1973, Lancet.

[30]  F. Wong,et al.  Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. , 2002, Immunity.

[31]  A. D. McLachlan,et al.  Rapid comparison of protein structures , 1982 .

[32]  Anastassis Perrakis,et al.  Automated protein model building combined with iterative structure refinement , 1999, Nature Structural Biology.

[33]  D. Finegood,et al.  Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. , 2003, The Journal of clinical investigation.

[34]  Mark M. Davis,et al.  Two-step binding mechanism for T-cell receptor recognition of peptide–MHC , 2002, Nature.

[35]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[36]  Wolfram Saenger,et al.  HLA-B27 Subtypes Differentially Associated with Disease Exhibit Subtle Structural Alterations* , 2002, The Journal of Biological Chemistry.

[37]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[38]  C. Carcassi,et al.  Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for disease pathogenesis. , 2003, Arthritis and rheumatism.

[39]  Vasso Apostolopoulos,et al.  Structural Comparison of Allogeneic and Syngeneic T Cell Receptor–Peptide-Major Histocompatibility Complex Complexes , 2002, The Journal of experimental medicine.

[40]  T A Jones,et al.  Electron-density map interpretation. , 1997, Methods in enzymology.

[41]  A. Rickinson,et al.  Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide , 1993, The Journal of experimental medicine.

[42]  W. Saenger,et al.  Thermodynamic and Structural Analysis of Peptide- and Allele-dependent Properties of Two HLA-B27 Subtypes Exhibiting Differential Disease Association* , 2004, Journal of Biological Chemistry.

[43]  Dagmar Ringe,et al.  POVScript+: a program for model and data visualization using persistence of vision ray-tracing , 2003 .

[44]  A. Ziegler,et al.  Ankylosing spondylitis: a β2m–deposition disease? , 2003 .

[45]  G. Greco,et al.  The naturally occurring polymorphism Asp116 → His116 , differentiating the ankylosing spondylitis‐associated HLA‐B*2705 from the non‐associated HLA‐B*2709 subtype, influences peptide‐specific CD8 T cell recognition , 1998, European journal of immunology.

[46]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[47]  L. Tuosto,et al.  Identification of a novel HLA-B27 subtype by restriction analysis of a cytotoxic gamma delta T cell clone. , 1994, Journal of immunology.

[48]  James Robinson,et al.  IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex , 2003, Nucleic Acids Res..

[49]  Bernard Malissen,et al.  What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity? , 2003, Trends in immunology.

[50]  A. Marina,et al.  The Peptide Repertoires of HLA-B27 Subtypes Differentially Associated to Spondyloarthropathy (B*2704 and B*2706) Differ by Specific Changes at Three Anchor Positions* , 2002, The Journal of Biological Chemistry.

[51]  P. Coulie,et al.  High-resolution structure of HLA-A*0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene. , 2001, Journal of molecular biology.

[52]  Takamasa Ueno,et al.  Single T Cell Receptor-Mediated Recognition of an Identical HIV-Derived Peptide Presented by Multiple HLA Class I Molecules1 , 2002, The Journal of Immunology.

[53]  A. van Leeuwen,et al.  Guilt by association: HLA-B27 and ankylosing spondylitis. , 1990, Immunology today.

[54]  E. Reinherz,et al.  Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. , 2003, Journal of molecular biology.

[55]  Arne Svejgaard,et al.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis , 2002, Nature Immunology.

[56]  Dean R. Madden,et al.  The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC , 1992, Cell.

[57]  J. Dausset,et al.  Spontaneous retinopathy in HLA-A29 transgenic mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[58]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[59]  M. Ramos,et al.  HLA-B27 and the pathogenesis of spondyloarthritis. , 2002, Tissue antigens.

[60]  Erin L. Schenk,et al.  Disparate binding of chaperone proteins by HLA-A subtypes , 2002, Immunogenetics.

[61]  D. Stuart,et al.  Antagonist HIV-1 Gag Peptides Induce Structural Changes in HLA B8 , 1996, The Journal of experimental medicine.

[62]  S. Tonegawa,et al.  Differences in the level of expression of class I major histocompatibility complex proteins on thymic epithelial and dendritic cells influence the decision of immature thymocytes between positive and negative selection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Y. Yoshikawa,et al.  Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. , 2003, American journal of human genetics.

[64]  Iannis Aifantis,et al.  Thymic selection revisited: how essential is it? , 2003, Immunological reviews.

[65]  V. Apostolopoulos,et al.  Crystal structure of a non-canonical high affinity peptide complexed with MHC class I: a novel use of alternative anchors. , 2002, Journal of molecular biology.

[66]  D. Mason,et al.  A very high level of crossreactivity is an essential feature of the T-cell receptor. , 1998, Immunology today.

[67]  T. Hirst,et al.  The B Subunit of Escherichia coli Heat-Labile Enterotoxin Enhances CD8+ Cytotoxic-T-Lymphocyte Killing of Epstein-Barr Virus-Infected Cell Lines , 2003, Journal of Virology.

[68]  D. Madden The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.

[69]  P. Kloetzel,et al.  Identification of HLA-B27-Restricted Peptides from the Chlamydia trachomatis Proteome with Possible Relevance to HLA-B27-Associated Diseases1 , 2001, The Journal of Immunology.

[70]  James McCluskey,et al.  A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition , 2003, The Journal of experimental medicine.